Abstract
The response of human acute myelogenous leukemia (AML) cells to four different hematopoietic growth factors (granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-1 beta (IL-1beta), interleukin-3 (IL-3), and stem cell factor (SCF)) and the relationship of the proliferative response of the AML cells to treatment outcome were studied. Proliferative responses were analyzed in 79 patients with de novo AML and 19 patients with AML arising from myelodysplastic syndrome (MDS). In de novo AML, a positive proliferative response (stimulation index >2) was seen in 65 to 75% of cases. AML cells arising from MDS had a much higher incidence of proliferative response to each growth factor (79 to 90%) and a much higher level of 3H-TdR incorporation. The relationship to treatment outcome was evaluated in 79 patients with de novo AML. The patients whose leukemic cells had a positive proliferative response to any growth factor, especially IL-3 and SCF, had a poorer outcome, ie a lower complete remission (CR) rate, shorter CR duration, and shorter survival. The outcome was particularly poor in patients whose leukemic cells had proliferative responses to all four or any of the growth factors, compared to patients whose leukemic cel...Continue Reading
Citations
May 30, 2002·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Ikuo MurohashiMasami Bessho
Jul 1, 2006·Acta Haematologica·Shuichi OtaMasahiro Asaka
Apr 25, 2015·Leukemia & Lymphoma·Maria E CardonaH Jose Arteaga
May 9, 2001·Leukemia & Lymphoma·M TaoH D Preisler
Jan 31, 2004·Pediatric Blood & Cancer·Csongor KissPéter Kovács
Nov 24, 2004·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Kazuma IkedaMine Harada
Jul 12, 2001·Annual Review of Biomedical Engineering·P W Zandstra, A Nagy
Jul 3, 2009·Cell Stem Cell·Liqing JinRichard B Lock
Sep 17, 2015·PloS One·Kazunori NakaseNaoyuki Katayama
Jul 18, 2001·Leukemia·W J RomboutsR E Ploemacher
Mar 10, 2001·Leukemia·G Jahns-StreubelW Hiddemann
Apr 14, 2000·Leukemia·W J RomboutsR E Ploemacher
Oct 19, 2001·Oncogene·J D Licht
Apr 21, 2001·Blood·B Z CarterM Andreeff
Sep 28, 2002·Blood·Ugo TestaCesare Peschle